A link between the accumulation of DNA damage and loss of multi-potency of human mesenchymal stromal cells by Alves, Hugo et al.
Introduction
Human mesenchymal stromal cells (hMSCs) represent an attrac-
tive cell source for clinical applications. They can be isolated from
different sources and are able to differentiate into several lineages
such as the osteogenic, adipogenic, chondrogenic, myogenic and
neurogenic lineages [1–5]. hMSCs are generally isolated from eas-
ily accessible tissues in a reproducible way and have a high expan-
sion potential, which makes them good candidates for the repair
and regeneration of a large variety of tissues. Currently, hMSCs
from bone marrow are the most common source of cells for ther-
apeutic applications. They are used in clinical trials mainly due to
proven efficacy in pre-clinical studies [6–9]. Potential applications
are repair of cardiovascular and central nervous system damage,
for pancreatic, renal, hepatic and solid organ transplantation, for
the use in the gastrointestinal tract, and for both orthopaedic and
haematopoietic applications (reviewed by Brooke et al.) [10].
Recently, new insights based on clinical experimentation also sug-
gest that MSCs secrete large quantities of bioactive factors with
both trophic and immunomodulatory activity, thus preventing
autoimmunity allowing allogenic MSCs to be used in a wide vari-
ety of clinical situations [11]. Because the yield of prospective
hMSC isolation is very low, expansion is a necessary step for clin-
ical application. Thus, successful clinical applications of hMSCs
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will rely on the ability to extensively expand them while maintain-
ing their multi-potency. Unfortunately, in vitro expansion of hMSCs
is associated with a gradual decrease and loss of differentiation
capacity of hMSCs, which currently represent one of the major bot-
tlenecks in cell-based clinical applications.  Although normally
stem cells cultured in low oxygen proliferate faster than in tradi-
tional 20% oxygen environments, there are several problems asso-
ciated with growing cells in a hypoxic environment. Low oxygen
levels tend to favour certain differentiation pathways in detriment
of others [12] and there are even reports about attenuation of dif-
ferentiation after cultivation of hMSCs in low oxygen [13, 14].
Furthermore, from a clinical/commercial point of view, the cultiva-
tion of hMSCs in low oxygen would require much more specialized
equipment and would be more labour intensive. Although it has
been shown that hMSCs can be expanded in vitro for several pop-
ulation doublings (PD), they ultimately stop dividing, a phenome-
non known as replicative senescence or the Hayflick limit after the
discovery by Leonard Hayflick that human diploid cell strains in
culture divide about 50 times before entering a senescence phase
[15]. The cellular senescence program is characterized by clear
morphological alterations culminating in growth arrest. This phe-
nomenon can be triggered by multiple mechanisms including
telomere shortening and uncapping, DNA damage accumulation,
proto-oncogene activation, epigenetic changes, stress and other
inducers like cytokines [16, 17]. Senescence was already impli-
cated in the loss of regenerative potential in ageing tissues [16, 18]
and although establishing a direct causal relationship between cel-
lular senescence and ageing might be complex, there is circum-
stantial evidence linking both processes. For clinical applications,
another important concern is the fact that hMSCs lose their differ-
entiation capacity (referred to as functional senescence in this arti-
cle) very soon during in vitro expansion as previously described
[19]. Despite several reports about the mechanisms that can drive
cellular senescence with ageing, little is known about mechanisms
that drive the loss of multi-potency in the early expansion phase of
tissue cultured hMSCs.
Some mutations in DNA repair pathways are associated with a
decrease in lifespan, an increase in the incidence of cancer and
genomic instability and symptoms of premature ageing. Examples
are the Ku80, TTDXpdR722W, Brca1 and Trp53 mutant mice [20,
21]. Three independent research teams recently published on the
link between age-related accumulation of DNA damage and
decline of stem-cell function [22–24]. The conclusion was that
with age, adult haematopoietic stem cell function declines and that
DNA damage and epigenetic modification may limit the regenera-
tive potential of those cells. They agree that ageing may result in
an accumulation of DNA mutations since stem cells are not pro-
tected from age-induced damage.
However, several issues remained unclear which lead us to
investigate whether DNA damage plays a role in early loss of
multi-potency observed during in vitro expansion of hMSC, the
susceptibility of adult mesenchymal stromal cells to accumulate
DNA damage, how effective DNA-repair activities are in these
cells, and to what extent this balance might contribute to the char-
acteristics of tissue ageing.
Materials and methods
Isolation and culture of hMSCs
Bone marrow aspirates were obtained from donors with written informed
consent and hMSCs were isolated and proliferated as previously described
[25]. Briefly, aspirates were resuspended using 20 G needles, plated at a
density of 5105 cells/cm2 and cultured in hMSC proliferation medium
(PM) containing -minimal essential medium (-MEM, Life Technologies,
Carlsbad, CA, USA), 10% foetal bovine serum (FBS, Cambrex), 0.2 mM
ascorbic acid (Asap, Life Technologies), 2 mM L-glutamine (Life
Technologies), 100 U/ml penicillin (Life Technologies), 10 g/ml strepto-
mycin (Life Technologies) and 1 ng/ml basic fibroblast growth factor (bFGF,
Instruchemie). Cells were grown at 37C in a humid atmosphere with 5%
CO2. Medium was refreshed twice a week and cells were used for further
subculturing or cryopreservation when reaching 80–90% confluency.
hMSC basic medium/control medium (BM) was composed of hMSC PM
without bFGF, hMSC osteogenic medium (OM) was composed of hMSC BM
supplemented with 108 M dexamethasone (dex, Sigma-Aldrich, St. Louis,
MO, USA) and hMSC mineralization medium (MM) was composed of BM
supplemented with 108 M dex and 0.01 M -glycerophosphate (Sigma).
After plating of the bone marrow aspirate, hMSCs were expanded in PM and
the cells obtained from the first trypsinization were considered as PD 
(population doubling) 0. Relative population doublings (RPD) refer to the
number of population doublings that cells had undergone, relative to PD 0.
Donors’ information is represented in Table S1.
Senescence associated--Galactosidase 
expression
hMSCs at different RPD were seeded at 15,000 cells/cm2 in 6-well plates
and proliferated in PM until 70–80% confluence was reached. Then,
cells were washed twice with PBS (Life Technologies), fixed with 4%
paraformaldehyde for 10 min., washed again three times with PBS and
stained overnight with a SA--gal Kit (Sigma) according to the manufac-
turer’s instructions. Cells were then counterstained with Mayer’s haema-
toxylin for 5 min. All chemicals were obtained from Sigma. Images were
taken at a 100 magnification.
Immunophenotyping of hMSCs
To characterize the population of hMSCs during expansion, cell-surface
marker expression was assessed. Low passage (RPD 6) and high passage
(RPD 20) cells were harvested by trypsin and incubated for 30 min. in block
buffer [PBS with 5% BSA (Sigma) and 0.05% NaN2], then incubated with pri-
mary antibodies (CD45, HLA-DR, CD19, CD90/Thy1, Endoglin/CD105,
Integrin M/CD11b from R&D Systems, CD34 and CD73 from Abcam)
diluted in wash buffer (PBS with 1% BSA and 0.05% NaN2) for 1 hr or with
isotype control antibodies. Cells were then washed three times with wash
buffer and incubated with secondary antibody (anti-mouse IgM or anti-mouse
IgG, conjugated with phycoerythrin from R&D systems) for 30 min. Samples
were then washed three times and resuspended in 250 l of wash buffer with
10 l of Viaprobe (Pharmingen) for live/dead cell staining. Only live cells were
used for further analysis. The percentage of cells expressing each marker and
the respective overlays of the histograms (RPD6 versus RPD20) were
assessed on FACSCalibur (Becton Dickinson Immunocytometry Systems).
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Acidic phosphatase and Alamar blue
Acidic phosphatase (ACP) and Alamar blue assays were performed to
measure the proliferative and metabolic status of the cells during the
experiment, respectively. The Alamar blue solution (BioSource;
Invitrogen, Carlsbad, CA, USA) was diluted 1:10 in culture medium, and
cells were incubated for 4 hrs. The Alamar blue solution from each well
was then transferred into 96-well plates, and fluorescence was measured
using a Perkin Elmer Luminescence Spectrometer LS50B. Results were
recorded by FL winlab 12. For the ACP determination, cells were lysed
with a 0.2% Triton X-100 solution in 100 mM potassium phosphate buffer
pH 7.8 and then incubated with 5 mM 4-nitrophenyl phosphate disodium
salt dissolved in 0.1 M sodium acetate, 0.1% Triton-X, pH 5.5. After 
1.5 hr at 37C, the reaction was stopped by adding 0.5 N sodium
 hydroxide and allowed to equilibrate for 10 min. The absorbance was then
measured at 405 nm.
Alkaline phosphatase (ALP) induction
For the biochemical ALP assay, hMSCs were seeded at 5000 cells/cm2 and
allowed to adhere for 10–15 hrs in BM and then cells were grown in OM
for 6 days. Each experiment was performed at least in triplicate with a neg-
ative control (cells grown in BM) and a positive control (cells grown in
OM). To avoid donor variation, all the experiments were performed with
cells from at least three independent donors. Results shown are usually
from one donor, unless stated otherwise and are representative for all the
donors tested. Briefly, cells were washed twice with PBS (Life technolo-
gies) and lysed using a 0.2% Triton X-100 solution in 100 mM PBS pH 7.8,
supplemented with a protease inhibitor cocktail (Roche Applied Science).
The lysate was incubated in the dark at 25C with CDP-Star substrate
(Roche) and allowed to react for 30 min. Luminescence was measured
using a VICTOR3 luminometer (Perkin Elmer) at 25C. The total ALP lumi-
nescence was normalized for cell number using ACP as readout. The data
were then analysed using Student’s t-test at P 	 0.05.
Mineralization and adipogenesis
Both assays were performed as described previously [19]. Experiments
were performed at least in triplicate using BM as negative control. In the
mineralization experiment, the calcium content was measured at 620 nm
(Bio-tek instruments) after 28 days in MM and expressed as percentage
reduction in calcium deposition compared to RPD 6 (passage 1), which
was set to 100%.
Immunofluorescence
Cells were grown on glass coverslips for at least 48 hrs prior to immunos-
taining to minimize stress as a consequence of passaging. Cells were
washed twice with PBS and fixed for 20 min. with freshly prepared 4%
paraformaldehyde in PBS. After permeabilization for 20 min. with PBST
(PBS with 0.2% Triton X-100), cells were blocked for 1 hr. The 53BP1 anti-
body (Novus) was diluted 1:500 in blocking buffer and incubated overnight
at 4C. Samples were then washed with TBST, incubated with Alexa-488
secondary antibody (Molecular Probes;  Invitrogen, Carlsbad, CA, USA)
and visualized by confocal laser scanning microscopy.
ImmunoFISH
The telomere dysfunction-induced (TIF) assay was performed as
described previously [26]. Briefly, after immunofluorescent staining
with 53BP1, cells were cross-linked with 4% paraformaldehyde in PBS
for 20 min. Then, cells were dehydrated using a series of 70%, 90% 
and 100% ethanol and air-dried. Nuclear DNA was denatured for 5 min.
at 80C in hybridization buffer containing 0.5 g/ml (C3TA2)3-Cy3-
labelled peptide nucleic acid (PNA) telomeric probe (Applied
Biosystems), 70% formamide, 12 mM Tris-HCl (pH 8), 5 mM KCl, 1 mM
MgCl2, 0.001% Triton X-100 and 2.5 mg/ml acetylated BSA. After
 denaturation, incubation was continued for 2 hrs at room temperature in
a humidified chamber. Cells were washed twice for 15 min. with 70%
formamide/2  SSC (0.3 M NaCl, 30 mM Na-citrate [pH 7]), followed by
a 10 min. wash with 2  SSC and a 10 min. wash with TBST. To rein-
force the 53BP1 signal, cells were incubated for 1 hr with an Alexa-488
conjugated anti-secondary antibody before mounting in a media
 containing DAPI.
Oxidative stress determination 
(8-OxoG and CM-H2DCFDA)
For the determination of oxidative stress load, two different methods
were employed. The first method was based on the detection of 
8-Oxoguanine (as part of the oxidized nucleotide 8-oxyguanosine) in
fixed permeabilized cells using flow cytometry.  Briefly, hMSCs from
 different RPD were fixed and permeabilized and then a FITC-labelled
protein conjugate specific for the 8-oxyguanine moity was added for 
1 hr, according to manufacturer’s instructions (Argutus Medical OxyDNA
test – BD Biosciences). The presence of the oxidized DNA was then
measured by FACS in at least 10,000 cells. The second method
 consisted in the direct detection of reactive oxygen metabolites as
described previously [27]. Shortly, adherent cells were harvested with
trypsin and combined with cells floating in the medium. Cells were then
washed and treated with 10 M (5-(and-6)-chloromethyl-2’7’-
dichlorodihydrofluorescein diacetate acetyl ester) CM-H2DCFDA
(Molecular Probes) for 30 min. at 37C. Ten thousand cells were then
analysed on a BD FACScan.
Western blot
For Western blot analysis, enzymatically dispersed cells were pelleted and
lysed using a solution of 0.2% Triton X-100 in potassium phosphate
buffer pH 7.8 containing a protease inhibitor cocktail (Roche Applied
Science). Protein concentration was quantified spectrophotometrically
using a BCA Protein Assay Kit (Pierce). Separated proteins were trans-
ferred electrophoretically to polyvinylidene difluoride membranes
(Immobilon-P Millipore). Blots were incubated overnight at 4C with
 primary antibodies: p16 (c-20, Santa Cruz Biotechnology); p21 (DCS60,
Cell Signaling Technology); -Actin, clone Ac-74 (Sigma) and the antibod-
ies from the DNA Damage Antibody Sampler Kit (Cell Signaling
Technology). Next, the membranes were incubated with peroxidase-
 conjugated secondary antibody, either Anti-Rabbit IgG or Anti-Mouse IgG
(Dako, Glostrup, Denmark), for 1 hr at room temperature. Antigen-
 antibody complexes were visualized by SuperSignal West Dura Extended
Duration Substrate (Thermo scientific).
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Unscheduled DNA synthesis (UDS)
For testing the nucleotide excision repair (NER) capacity, hMSCs were
seeded onto coverslips and grown in medium without thymidine and
switched to medium without FBS 24 hrs prior to the start of the experi-
ment. Cells were then washed with PBS, irradiated with 16 J/m2 UV-C
(Philips TUV lamp) and subsequently incubated for 2.5 hrs in culture
medium containing 10 Ci/ml 3H-thymidine (Amersham International PLC;
GE Healthcare, Little Chalfont, UK). For analysis, cells were fixed in Bouin
fixative and subjected to autoradiography as previously described [28].
Repair capacity was quantified by counting autoradiographic grains above
the nuclei of 
 25 cells. UDS levels are expressed as the mean of grains
per fixed area plus standard error for each PD.
Exposure to a DNA damage inducer
To assess the effects of oxidative stress on ALP expression, early passage
cells (RPD 10) were plated at 2000 cells/cm2 and treated with hydrogen
peroxide (H2O2, Sigma) or paraquat (Sigma) and grown either in BM or
OM for 6 days. After this period, ALP expression was assessed using the
biochemical method described above. In order to evaluate the DNA
 damage load, cells were expanded in PM and treated with either hydrogen
peroxide or paraquat. The percentage of DNA damage positive cells and
the average foci per cell were determined by immunofluorescence stain-
ing of 53BP1.
Results
Replicative senescence upon in vitro expansion 
of hMSCs
In order to investigate the differentiation capacity with respect to
expansion, hMSCs from two donors were expanded until cessa-
tion of growth. As expected, hMSCs presented a continuous
decrease in proliferation rate with increased time in culture 
(Fig. 1A). After an initial difference, both donors exhibited a simi-
lar level of PD/day until around 60 days in culture. At this point,
the cells from donor 36 stopped proliferating while the cells from
donor 24 displayed a temporary recovery followed by a permanent
growth arrest. Although late passage cells did not proliferate, they
were able to be maintained viable in culture for at least 3 more
months before the experiment was ended. No spontaneous
immortalization of hMSCs was ever observed and no clonal
expansion was observed during this period of in vitro expansion.
An evident change in cell morphology was observed with
increasing time of culture (Fig. S1A). In RPD 0, cells presented a
fibroblastic-like appearance that progressed toward a more spread
morphology characterized by enlarged and flattened cytoplasm,
increased granularity and heterogeneous cell shape. hMSCs from
low RPD grew homogeneously while in higher RPD they grew in
cluster with neighbouring cells, leaving large interspaces between
the clusters (Fig. S1A, RPD25). Late passage cells also displayed
an increased expression of senescence-associated -galactosi-
dase (SA--gal), a common marker for senescent cells (Fig. 1B).
hMSCs after minimally or extensively expansion were pheno-
typically similar, presenting the same percentage of marker
expression (Fig. S2). hMSCs were negative for CD11b, CD19,
CD34 and CD45 and positive for CD73, CD90 and CD105. HLA-DR
was present in 6% of the cells independent of the passage.
Gradual loss of the differentiation capacity 
of hMSCs after in vitro expansion
To determine the differentiation capacity of hMSC during in vitro
culture, we performed both in vitro osteogenic and adipogenic
assays at different RPD. We observed a decrease in the levels of
ALP of cells grown in BM mainly from RPD 13 to the following
PDs. We also observed a decrease in the dexamethasone-induced
ALP levels (an early marker for bone formation) with increasing
RPD (Fig. 1C). At RPD 13 (passage 3) both the basal as well as the
induced levels of ALP were already very low and the cells were no
longer responsive to dexamethasone. A decline in calcium deposi-
tion (a late marker for in vitro osteogenesis) was also observed
with culturing (Fig. S1B). This decrease was most pronounced
(approximately 70% reduction in calcium deposition) between
RPD 17 and RPD 20. After RPD 20, the cells lost their ability to
mineralize in vitro. In addition, we also tested the ability of the
expanded hMSC to differentiate into the adipogenic lineage. We
observed loss of adipogenic potential during expansion (Fig. S1C).
At RPD 20, a small subset of hMSC was still able to differentiate
into the adipogenic lineage, but it was proportionally considerably
less than in hMSC from early PDs.
DNA damage accumulation and DNA damage
pathway activation during in vitro expansion
To evaluate the relation between DNA damage and in vitro expan-
sion, immunofluorescence staining of p53 binding protein 1
(53BP1) and TIF assays were performed at several RPD [29–32].
We observed that with increasing PD there was a significant
increase in the number of nuclei containing 53BP1 foci, a marker
of DNA damage (Fig. 2A). Interestingly, we also observed an
increase in telomere-associated DNA damage, demonstrated by
the co-localization of 53BP1 staining with a telomeric probe (Fig. 2B).
In cells after 27 RPD or more (passage 8), the telomeric signal
could no longer be detected. To determine the changes in oxida-
tive levels that hMSCs face during expansion, we quantified the
presence of 8-oxoguanine (Fig. 2C) and the presence of reactive
oxygen metabolites (Fig. 2D). Both assays demonstrated that dur-
ing expansion hMSCs are exposed to increased oxidative stress
levels. These data demonstrate that in vitro cultured hMSCs accu-
mulate DNA damage upon expansion.
Next, we performed Western blot analysis on hMSCs at different
RPDs and analysed the abundance of proteins involved in the DNA
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damage response pathway, such as phospho-p53 (Ser15), p16 
(c-20) and p21Waf1/Cip1 (Fig. 3A). In accordance with the previous
results, we observed an activation of the DNA damage response
pathway with time of culture. There was a particularly strong
increase from RPD 10 to RPD 17. We suggested that DNA dam-
age accumulation is due to impaired DNA repair mechanisms in
late passage cells. We analysed the capacity of NER because it is
involved in the repair of many types of DNA damage including the
ones induced by reactive oxygen species associated with prema-
ture ageing phenotypes. To this end, hMSC from different RPD
were seeded onto coverslips and irradiated with UV after which we
measured the incorporation of 3H-thymidine. With increased PD,
there was no significant change in the NER capacity (Fig. 3B).
DNA damage induction is associated with loss 
of multi-potency
The data described above show a correlation between DNA
damage accumulation and loss of hMSC multi-potency but
whether this is a causal relation is not known. To mimic the
increased DNA damage load in culture expanded hMSCs, we
induced DNA damage using hydrogen peroxide (H2O2) and
paraquat (PQ). Hydrogen peroxide has been the most com-
monly used source of oxidative stress and known to induce fea-
tures similar to replicative senescence like: morphology
changes, senescence-associated galactosidade activity, cell
cycle regulation [33–36]. Being paraquat another extensively
used compound to induce superoxide production causing
extensive mitochondrial damage [37–39].
First, we established a dose-response curve of hydrogen per-
oxide on proliferation of hMSCs. Up to 50 M H2O2, the differ-
ences observed were not statistically significant (Fig. 4A). For
paraquat, a concentration of 5 M and 10 M was used based
on our previous experiments (data not shown). Based on this,
we choose two concentrations of H2O2 (30 and 50 M) and two
of paraquat (5 and 10 M) to treat hMSCs, where after 6 days,
both DNA damage accumulation and ALP induction was
assessed and compared to the control situation. Under these
conditions, DNA damage accumulation occurred evidenced by
the increase in 53BP1 positive cells [33.33  4.9% in the con-
trol situation to 52.83  6% in 30 M H2O2 treated hMSCs and
51.8  4.7 in 5 M paraquat treated cells, (Fig. 4B)] and the
number of 53BP1 foci per cell which increased from 0.50  0.05
to 1.68  0.19 (H2O2, 30 M) or 0.77  0.06 in (paraquat, 
5 M) in treated cells (Fig. 4C). When a stronger concentration
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Fig. 1 Long-term in vitro
expansion of hMSCs leads to
loss of multi-potency. (A)
Growth profiles of hMSCs 
in vitro depicted by the num-
ber of population doublings
per day plotted against culture
period. (B) Phase-contrast
photo of hMSCs at RPD 25.
At RPD 25, most of the cells
express SA--Galactosidase
(black arrows). With increas-
ing time of culture not only
more cells were positive for
SA- -Galactosidase but also
the staining was more
intense (data not shown). (C)
Effect of expansion in the
expression of ALP, both in
control and dexamethasone-
treated cells. ALP expression
was analysed by CDP-STAR
base luminescence assay
and corrected for the cell
number. Error bars represent
standard deviation. Statistical
analysis was performed using
one-way ANOVA and Tukey
post-test with a significance
level of 0.05. * represents 
P 	 0.01 to 0.05 and 
*** P 	 0.001.
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of DNA damage inducer was used, both the percentage of dam-
aged cells (53BP1 positive, Fig. 4B) and average foci per cell
(Fig. 4C) increased even further. When a DNA-damage inducer
was used, an increase in the -galactosidase activity was also
observed (Fig. S3). Exposure of hMSCs for 6 days to DNA dam-
age inducers did not have an effect on ALP activity in BM (except
for cells treated with 50 M H2O2), but it did significantly inhibit
dexamethasone-induced ALP expression in all the conditions
tested (Fig. 4D). Mineralization was also significantly repressed
by the usage of any of the inducers (Fig. 4E).
Discussion
Human mesenchymal stromal cells are multi-potent cells, which
are able to differentiate into several lineages [1–5]. They can be
isolated from bone marrow and other tissues and appear not to
require tissue matching between MSC donor and recipient [40].
Therefore, they are promising candidates for cell-based therapies
for a number of regenerative conditions [10]. However, the attrac-
tiveness of this cell source for regenerative medicine depends
largely on the possibility to expand, differentiate and induce the
desired effect in vivo after the expansion period. It is therefore cru-
cial to analyse the effect of long-term in vitro expansion.
There is one report claiming spontaneous immortalization of
adipose-derived MSCs [41], although we never observed it in cells
from at least six donors that we followed up for 3 months after cell
cycle arrest. Our observation is supported by a number of other
studies [19, 42, 43]. For example, the consequences of long-term
in vitro expansion have also been evaluated in MSCs derived from
bone marrow and adipose tissue of both human beings and rhe-
sus macaques [44]. The authors observed that, unlike rhesus
MSCs, human MSCs did not develop polyploidy throughout the
prolonged culture and no chromosomal rearrangements were
detected in any of the human MSC samples analysed at any pas-
sage. The only observation we made that may resemble sponta-
neous transformation was a transient and partial recovery in cell
morphology and proliferation in cells from one donor. However,
after a few cell divisions, the cells permanently arrested.
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Fig. 2 Accumulation of 53BP1, telomeric 53BP1 foci and oxidative stress after expansion of hMSCs. Cells were immunostained with 53BP1 antibody.
At the indicated RPD, 53BP1 positive cells were quantified (A). Cells were processed by immunoFISH to visualize 53BP1 foci at the telomeres. At the
indicated RPD, TIF-positive cells were quantified (B). A cell was considered TIF-positive if 
50% of its 53BP1 foci co-localized with telomeres (PNA).
Green, blue and red colour channels represent, respectively: 53BP1, DAPI and telomeres (PNA). Arrows represent co-localization of 53BP1 foci and
telomeric probe. The level of 8-oxoguanine (C) and oxidative stress (D) was measured at the respective RPD by FACS in at least 10,000 cells. Error bars
represent standard deviation. Statistical analysis was performed using one-way ANOVA and Tukey post-test with a significance level of 0.05. * P 	 0.05,
** P 	 0.01 and *** P 	 0.001.
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Fig. 3 Activation of the DNA damage signalling pathway and efficiency of NER. Samples from different RPD were analysed by Western blotting for p16
and p21 protein expression and p53 and BRCA1 protein phosphorilation (A). -actin served as loading control. NER efficiency was determined at sev-
eral RPD after in vitro expansion using the unscheduled DNA synthesis assays. Error bars represent standard deviation. Statistical analysis was per-
formed using one-way ANOVA and Tukey post-test with a significance level of 0.05. ** P 	 0.01 and *** P 	 0.001.
Fig. 4 Effects of the exposure of DNA damage inducers on the differentiation potential of hMSCs. Effect of variant concentrations of hydrogen peroxide
(H2O2) on the proliferation of hMSCs after 6 days of exposure (A). Effect of continuous exposure (6 days) of H2O2 and paraquat on the differentiation
potential (ALP levels and mineralization) of hMSCs (D, E) and on the DNA damage load (B, C). DNA damage load was assessed by quantifying the per-
centage of 53BP1 positive cells (B) and 53BP1 foci per cell (C). Data are expressed as total ALP normalized for cell number repeated in at least three
different donors. Error bars represent standard deviation. Statistical analysis was performed using one-way ANOVA and Tukey post-test with a signifi-
cance level of 0.05. * P 	 0.05, ** P 	 0.01 and *** P 	 0.001.
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Although immortalization was not observed, in vitro expansion
did negatively affect the hMSCs from an early time-point of cul-
ture, seen by the decrease in both the proliferation rate and differ-
entiation potential. The decrease in proliferation rate seems con-
stant until senescence hits in after about 20 population doublings
but starts right from the beginning of the expansion period. There
are various stresses that can induce replicative senescence, i.e.
oxidative stress, oncogene overexpression and telomere shorten-
ing. The response to oncogene overexpression is thought to be a
tumour-suppressive mechanism, by which cells prevent the
uncontrolled proliferation due to oncogene activation. For exam-
ple, normal cells senesce in response to the activation of certain
oncogenes, such as RAS or of its downstream effectors [45, 46].
Oncogene-mediated senescence is most likely to occur late during
the expansion phase, because mutagenic events have to occur.
However, we observed an instant decline in proliferative capacity
in cultured hMSCs, which makes the oncogene theory not likely,
although we cannot exclude it.
The decline in proliferation and differentiation can also be
caused by telomere shortening. During cell expansion, a gradual
shortening of the average length of telomeres is observed eventu-
ally leading to telomere uncapping. Once unprotected, dysfunc-
tional telomeres activate a DNA damage response resulting in per-
manent cell cycle arrest. We formerly reported that there is a direct
association between the age of primates and the levels of telom-
ere-dysfunction found in their skin fibroblasts, providing a clear
association between telomere dysfunction and senescence in vivo
[47]. In this respect, it is important to note that telomere length
varies among the MSC population and therefore, initiation of the
senescence program is expected to start at different numbers of
population doublings for different subclones in an MSC culture.
However, we never observed clonal expansion in culture. Although
telomere length was not measured, we could not detect the telom-
eres at RPD27, which suggested to us that telomere shortening
contributes to the last stages of senescence and to terminal cell
cycle arrest.
In this article, we also describe that with increasing time of cul-
ture, there is an increase in the DNA damage load, even though the
capacity of the NER pathways remains unchanged. Recently, in a
complementary study, the initial step of base excision repair in
uncultured and cultured adipose-tissue derived mesenchymal
stem cells (AT-MSCs) was compared [48]. By analysing the base
removal activities (8-oxoG, uracil, 5-ohU, and &epsiv;A lesions)
and expression levels of relevant DNA glycosylases, the authors
concluded that the DNA glycosylase activities tested were stable
throughout culturing, suggesting that high DNA repair activity
(base excision repair) is maintained, although a slight decrease in
8-oxoG removal activity was observed at senescence. The gene
expression analyses on the DNA glycosylases showed no substan-
tial changes in mRNA expression. There are, however, reports
where genes related to DNA repair were repressed after in vitro
culturing, although, most refer to experiments performed in non-
Human cells, so possible species variation must be taken into
 consideration [49–51]. These results suggest that the DNA dam-
age load which the hMSCs are facing in culture is higher than what
is possible to be repaired, leading to a constant DNA damage
accumulation, activation of the DNA damage signalling pathway
and ultimately to loss of differentiation capacity and cellular senes-
cence. Previous reports demonstrated that DNA damage accumu-
lation due to deficiencies in DNA damage repair not only induces
premature ageing phenotypes [52] but also limit the function of
haematopoietic stem cells with age [23, 24].  A recent publication
also suggests that the senescence growth arrest in hMSCs after 
in vitro expansion may result from activation of stress signalling
pathways and consequent onset of stress responses, due in part
to (reactive oxygen species) ROS production during prolonged 
in vitro culture [53]. The authors by introducing Wip1 (wild-type
p53 inducible phosphatase-1), a stress signalling modulator, man-
age to extend the life span of hMSCs and to overcome oncogenic
stress mediated growth arrest.
In addition to the decline in proliferation, we observed a
decrease in the differentiation potential. In contrast to two previ-
ous reports which claim maintenance or increased propensity for
osteogenic differentiation of hMSCs after in vitro expansion [2,
54], our data show that osteogenesis is more affected by the 
in vitro culture period than adipogenesis. These results are con-
firmed by several other reports [19, 42–43, 55]. For instance, it
was shown that after 20 population doublings, hMSCs were
unable to mineralize and presented a negligible ALP induction by
dexamethasone. Moreover, the amount of bone formed by hMSCs
after implantation in nude mice displayed a dependence on the 
in vitro age of the cells [42]. Interestingly, the loss of differentia-
tion capacity observed during in vitro expansion of hMSCs pre-
cedes terminal senescence and coincides with the activation of the
DNA damage signalling pathways. We suggest that with expansion,
there is an increase in DNA damage content, and therefore activa-
tion of the DNA damage signalling pathways, which results in a
decrease in differentiation potential. In accordance, we used hydro-
gen peroxide and paraquat to increase the level of DNA damage in
hMSCs at a concentration that did not affect significantly the pro-
liferation. These concentrations proved still to be enough to
increase DNA damage levels and affect the differentiation capacity.
These results, in combination with the knowledge that, with age,
adult haematopoietic stem cell function declines and that DNA
damage and epigenetic modification limit the regenerative potential
of those cells, seem to further substantiate the possible link
between DNA damage accumulation and loss of stemness [22–24].
The significant drop in quality of culture expanded hMSCs
poses some concerns considering the possibility to use these cells
for clinical applications. We conclude that hMSCs are susceptible
to accumulate DNA damage upon in vitro expansion and that this
DNA damage accumulation correlates directly with the observed
loss of multi-potency after hMSC in vitro expansion. Although they
maintained an effective NER activity, there was still a progressive
DNA damage accumulation, which might be one of the mecha-
nisms underlying age-related loss of tissue function.
These results suggest that hMSCs should be minimally
expanded and leave a window of possibility for the use and screen
of molecules that might circumvent or reduce the in vitro DNA
damage accumulation, leading to a possible extension of the
© 2009 The Authors
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 differentiation capacity and making them even more suitable for
clinical applications.
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Fig. S1 hMSCS morphology and differentiation is affected by 
in vitro expansion (A) Phase-contrast photos of hMSCs at different
RPD, 40 magnification. An evident change in cell size and 
morphology can be observed with increased time of culture. (B)
Change in the mineralization potential after in vitro expansion.
Relative calcium accumulation by hMSCs in MM after 28 days,
expressed as  percentage reduction in calcium deposition ability 
over passages compared to RPD 6. No detectable calcium was
measured in hMSCs cultured in BM (data not shown). (C) Phase-
contrast images of hMSC in adipogenic medium at different
RPD. Adipocytes are stained with Oil red O and visualized at 40
magnification. Error bars represent standard deviation. Statistical
analysis was performed using one-way ANOVA and Tukey post-test
with a significance level of 0.05. * represents P 	 0.01 to 0.05 
and *** P 	 0.001.
Fig. S2 Immunophenotype of hMSCs (RPD 6 versus RPD 20).
Representative overlay of flow cytometry histograms of hMSCs
from human bone marrow are presented. Black histogram, RPD 6
and green line, histogram of RPD 20.
Fig. S3 Senescence-associated -galactosidase expression after
DNA damage induction. RPD 6 cells were exposed to 0, 30 or 
50 M of H2O2 for 6 days after which cells were stained for 
SA--galactosidase.
Table S1 Information relative to the hMSCs donors used in this
article.
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Figure S1. hMSCS morphology and differentiation is affected by in vitro expansion 
A) Phase-contrast photos of hMSCs at different RPD, x40 magnification. An evident change in 
cell size and morphology can be observed with increased time of culture. B) Change in the 
mineralization potential after in vitro expansion. Relative calcium accumulation by hMSCs in 
MM after 28 days, expressed as percentage reduction in calcium deposition ability over passages 
compared to RPD 6. No detectable calcium was measured in hMSCs cultured in BM (data not 
shown). C) Phase-contrast images of hMSC in adipogenic medium at different RPD. Adipocytes 
are stained with Oil red O and visualized at x40 magnification. Error bars represent standard 
deviation. Statistical analysis was performed using one-way ANOVA and Tukey post-test with a 
significance level of 0.05. * represents p < 0.01 to 0.05 and *** p < 0.001. 
 
Figure S2. Immunophenotype of hMSCs (RPD 6 vs RPD 20). Representative overlay of flow 
cytometry histograms of hMSCs from human bone marrow are presented. Black histogram, RPD 
6 and green line, histogram of RPD 20. 
 
Figure S3. Senescence-Associated β-galactosidase expression after DNA damage induction. 
RPD 6 cells were exposed to 0, 30 or 50 µM of H2O2 for 6days after which cells were stained for 
SA-β-galactosidase. 
 
Table S4. Information relative to the hMSCs donors used on this manuscript. 
 
